Skip to main content
Premium Trial:

Request an Annual Quote

Clear Labs Raises $13M in Series B Financing

NEW YORK (GenomeWeb) – Food testing and analytics firm Clear Labs announced it has raised $13 million in a Series B financing round.

Wing VC led the round, with participation from Google Ventures, Tencent, Khosla Ventures, and Felicis Ventures. Clear Labs said it plans to use the funding to extend its commercial reach in the US, Europe and Asia, expand its family of food tests, build its commercial team, and advance its software.

The firm is offering next-generation sequencing testing for food manufacturers and retailers. In a statement, Clear Labs said its analytics pipeline will translate molecular testing into actionable information for its customers.

"This new funding will help us reach food companies on a global scale," Clear Labs Co-Founder and CEO Sasan Amini added. "Both our family of NGS-based food tests and software analytics offerings have huge implications for the scalability and accessibility of food safety and quality measures."

Michael Taylor, a former US Food and Drug Administration deputy commissioner for foods and veterinary medicine and newly appointed member of Clear Labs' board of directors, added that as sequencing costs go down and speed goes up, "it's only a matter of time before NGS will be applied more broadly to improve food safety management systems and prevent safety problems."

Clear Labs was launched last year with $6.5 million in Series A private financing.


Ed. note: The firm subsequently raised another $3.3 million in the Series B round, bringing the total to $16.3 million.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.